», «treatment», «frequency», «prevalence», «genotype-phenotype correlation», « modifier
genes». Results
Aim: to study
gene enzyme polymorphism of xenobiotic detoxification in patients suffered from HFRS
Nasyrova, Regina F,
Vaiman, Elena E,
Repkina, Vera V,
Khasanova, Aiperi K,
Asadullin, Azat R,
Shipulin, German A,
Altynbekov, Kuanysh S,
Al-Zamil, Mustafa,
Petrova, Marina M,
Shnayder, Natalia A (2023) IA) from the DRD2
gene as well as the TT genotype rs13212041 (77461407 C>T) from the HTR1B
gene were found
Dorling, L.,
Carvalho, S.,
Allen, J.,
González-Neira, A.,
Luccarini, C.,
Wahlström, C.,
Pooley, K.A.,
Parsons, M.T.,
Fortuno, C.,
Wang, Q.,
Bolla, M.K.,
Dennis, J.,
Bermisheva, M.,
Khusnutdinova, E.,
Prokofyeva, D.,
other additional authors (2021) BACKGROUND Genetic testing for breast cancer susceptibility is widely used, but for many
genesKhusnutdinova, E.K.,
Dzhemileva, L.U.,
Lobov, S.L.,
Kuznetzov, D.U.,
Nazirova, A.G.,
Nurgalina, E.M.,
Barashkov, N.A.,
Fedorova, S.A. (2017) carrier frequency of c.35delG,
c.167delT and c.235delC mutations of the GJB2
gene in 17 populations
Korytina, G.F.,
Akhmadishina, L.Z.,
Kochetova, O.V.,
Burduk, Yu.V.,
Aznabaeva, Yu.G.,
Zagidullin, Sh.Z.,
Victorova, T.V. (2014) Polymorphisms of the CHRNA5/A3, CYP2A6, NQO1, XPC, XRCC1, CRCC3, XPD, and XPA
genes were tested